Is avoidable mortality a good measure of the quality of hospital care? Dr Helen Hogan Clinical Senior Lecturer in Public Health London School of Hygiene.

Slides:



Advertisements
Similar presentations
National Reporting & Learning System (NRLS) Reporting systems are vital in providing a core of sound, representative information on which to base analysis.
Advertisements

Aim of programme to apply the principles of risk management to practical situations and relate these to personal experiences to improve the quality of.
S Seven Steps to Medication Safety : Identifying and Reporting Medication Safety Incidents Bite-sized training P S East & South East England Specialist.
Building the highest quality services in the country Nigel Barnes March 2008.
The Healthcare Commission and Patient Safety AvMA NPSA Patients for patients safety partnership event Richard Elson 18th March 2008.
Mike Keen, CEO, Kent LPC. Why is change needed? NHS England states that: Primary care services face increasingly unsustainable pressures Community pharmacy.
Walsall Healthcare NHS Trust Medicines Management.
Inefficiencies in provision of acute care with poor use of estate Dependence on hospital care with failure to transfer care to community Need for more.
HIV in the United Kingdom: 2013 HIV and AIDS Reporting Section Centre for Infectious Disease Surveillance and Control (CIDSC) Public Health England London,
Electronic Medication Management (eMM) Concepts and Definitions Dr Stephen Chu.
Protecting patients- now and in the future Linda Matthew Senior Pharmacist National Patient Safety Agency.
Questions or comments on this presentation can be addressed to You can pick and choose the elements.
Support and Assessment for Fall Emergencies (SAFE) Trial An evaluation of the costs and benefits of computerised on-scene decision support for emergency.
OPTIMISING MEDICINES USE GRAHAM DAVIES Professor of Clinical Pharmacy & Therapeutics Institute of Pharmaceutical Science King’s College London.
West Hertfordshire Hospitals NHS Trust Analysing mortality data derived from Secondary User Services.
Patient Safety and Patient Identification Chris Ranger Partnership Development Manager (NHS Connecting for Health and Informing Healthcare)
Death and the Infirmary Standardised Mortality at Hull & East Yorkshire Hospitals NHS Trust.
Mortality measures 18 March 2008 Mike Davidge. Mortality measures What measure are we using? To track the progress of the campaign we are using Brian.
Drug and Therapeutics Committee Session 7A. Identifying Problems with Medicine Use: Indicator Studies.
NHS Highland Quality and Patient Safety Framework
*Data from July-December 2013 is for GNEF CHP only. From January 2014 onwards this will also include Acute Services Division data. SAFEEFFECTIVE C difficile.
Oxford AHSN Patient Safety Collaborative November
National Confidential Inquiry into Suicide and Homicide by People with Mental Illness National Learning Disability Review Function Options Appraisal Report.
The Health Roundtable 4-4c_HRT1215-Session_CLARK_PCHosp_QLD TPCH: Using Data to Improve Performance – The Clinical Dashboard Presenter: Kevin Clark The.
 Definitions  Goals of automation in pharmacy  Advantages/disadvantages of automation  Application of automation to the medication use process  Clinical.
1955 when Codman who is also known as father of Patient safety looked at the outcome of patient care 1984 Anaesthesia patient safety foundation established.
The Health Roundtable Using IHI Global Trigger Tool to monitor Adverse Drug Events Presenter: Helen Ward The Prince Charles Hospital _ Qld Innovation Poster.
Reducing Medication Errors findings of the National Clinical Governance Protected Time Project Paul MooreClinical Governance Manager.
Patient Safety in Primary Care The Linneaus Collaboration www. linneaus-pc.eu Aneez Esmail Professor of General Practice University of Manchester (UK)
Prescribing Errors in General Practice The PRACtICe Study (2012) GMC Investigating Prevalence and Causes.
Preventing Surgical Complications Prevent Harm from High Alert Medication- Anticoagulants in Primary Care Insert Date here Presenter:
Mapping and Implementing a Safe Medicines Pathway Jennifer Dorey Pharmaceutical Adviser, NHS South --- South Central.
‘Active Risk Management at Rotherham’ Rotherham NHS FT QUEST presentation 24th June 2011 Dr Trisha Bain.
Scottish Patient Safety Programme – Pharmacist Engagement Gordon Thomson Arlene Coulson Shadi Botros.
HIV and STI Department, Health Protection Agency - Colindale HIV and AIDS Reporting System HIV in the United Kingdom: 2012 Overview.
Standard 4: Medication Safety Advice Centre Network Meeting Margaret Duguid Pharmaceutical Advisor February 2013.
What do we know about overall trends in patient safety in the USA? Patrick S. Romano, MD MPH Professor of Medicine and Pediatrics University of California,
Step 1 The NHS Safety Thermometer 10 Steps to Success Series! Understanding how we measure harm in healthcare Welcome to this recording on the NHS.
National E-Health Transition Authority 1 Electronic Medication Management (eMM) Dr Stephen Chu Concepts and Definitions.
Anticoagulants Reducing the risk Amanda Powell & Sue Wooller May 2014.
Reducing Mortality in AKI/ SEPSIS Patients Aintree University Hospital DEBBIE COWELL/SUE GALLAGHER 2015.
NHS Outcomes Framework Key Measure is replicated in Department of Health’s proposed contribution to the cross-Government Transparency Framework Measure.
PSF FINAL SHOWCASE EVENT 29 TH SEPTEMBER 2015
A Claims Database Approach to Evaluating Cardiovascular Safety of ADHD Medications A. J. Allen, M.D., Ph.D. Child Psychiatrist, Pharmacologist Global Medical.
Kent, Surrey and Sussex Patient Safety Collaborative Pressure Damage is Everybody's Business A National Perspective Caroline Lecko Patient.
Is avoidable mortality a good measure of the quality of healthcare? Dr Helen Hogan Clinical Senior Lecturer in Public Health London School of Hygiene and.
European Patients’ Academy on Therapeutic Innovation Introduction to pharmacovigilance Monitoring the safety of medicines.
Performance assessment A performance assessment framework is a collation of statistics across a district or within a hospital and is far removed from.
1 Hinchingbrooke Health Care NHS Trust CQC report October 2015 Inspection Chair: Helen Coe Team Leader: Fiona Allinson Quality Summit 2 February 2016.
Medicines Reconciliation A Whole System Approach Arlene Coulson Principal Clinical Pharmacist, Specialist Services Gordon Thomson Principal Clinical Pharmacist,
Supporting Trusts to Use a Broader Range of Data Sources for Monitoring Patient Safety A toolkit for Patient Safety Managers Produced by Dr Helen Hogan,
D Monnery, R Ellis, S Hammersley Leighton Hospital, Crewe.
Dr Michelle Webb Renal Consultant, Associate Medical Director Patient Safety, East Kent Hospitals University NHS Foundation Trust and Co-lead for Sepsis.
Risk Management in the National Health Service in England Stuart Emslie Head of Controls Assurance Department of Health, England ISO General Assembly 2001,
We’re counting the benefits of EPR Find out at: epr.this.nhs.uk We’re counting the benefits of EPR Find out at: epr.this.nhs.uk The introduction of EPR.
Improving the Quality of Local Healthcare Services: Improving the Quality of Local Healthcare Services: The role of commissioning Julia Barton, Chief Quality.
An Audit to Determine if Prescribers are Reviewing Antimicrobial Prescriptions Hours After Initiation. Natalie Holman, Emma Cramp, Joy Baruah Hinchingbrooke.
A ssociation of Public Health Observatories Hospital Activity data Roy Maxwell SWPHO & Bristol University Dr Richard Wilson Sandwell PCT.
Rory M Marks, John Z Ayanian, Brahmajee K Nallamothu
Right Care Deep Dives NEW Devon CCG Blood Disorders.
Velindre NHS Trust June 10th 2011
Powys teaching Health Board
9. Introduction to signal detection
Medication Safety Dr. Kanar Hidayat
Powys teaching Health Board
National Learning Session - 10th June 2011
Medication Safety Dr. Kanar Hidayat
Cardiff and Vale UHB Dr Graham Shortland
Gregory Levin, FDA/CDER/OTS/OB/DBIII
Presentation transcript:

Is avoidable mortality a good measure of the quality of hospital care? Dr Helen Hogan Clinical Senior Lecturer in Public Health London School of Hygiene and Tropical Medicine

Outline What drives interest in avoidable mortality Problems with use as a measure of hospital quality Approaches to measurement and what we have learned Local and national developments The future

Why it matters?

Limitations of avoidable deaths a measure of quality

Measuring avoidable death using population-level data Hospital-wide Standardised Mortality Ratios (HSMR/ SHMI/ RAMI) Coded adverse events linked to death Known avoidable harms linked to death Patient Safety Indicators Prospective surveillance systems

N Engl J Med 2010;363: Compared four commercially available methods for deriving hospital wide SMRs from data on hospitals in Massachusetts 12 out of 28 (43%)- one method concluded the hospital had significantly higher-than-expected mortality while another method concluded same hospital had significantly lower-than-expected mortality

Measuring avoidable deaths at patient level

What have we learnt so far Preventable Incidents Survival and Mortality studies (PRISM) 1 and 2 Co-applicants: Nick Black, Frances Healy, Graham Neale, Richard Thomson, Charles Vincent, Ara Darzi Funders: NIHR Research for Patient Benefit, DH PRP

PRISM 1 Study 2010/2011 Aims: – identify ‘problems in care’ and contributory factors – estimate proportion of avoidable hospital deaths – estimate years of life lost Method: – RCRR (1000 adult deaths across 10 acute Trusts in England) – Trained, retired doctors with standard form

Findings 75% good or excellent care 11.3% ‘problem in care’ contributing to death 5.2% deaths probably avoidable – range 3% - 8% (low variation between Trusts) – estimate 11,859 avoidable adult deaths/year in England NHS Life expectancy of avoidable death patients – 60% patients had life expectancy less than 12 months Inter-rater reliability Kappa 0.49

Problems in care identified in cases of preventable death Stage of patient journey Types of problem identified PreadmissionPoor monitoring of warfarin Delays in admission for hospital procedure Contraindicated drug prescribed in outpatients Early in admission Failure to diagnose Delayed diagnosis Wrong diagnosis Failure to identify the severity of underlying conditions and risks posed by the chosen therapeutic approach Failure to optimise preoperative state Care during a procedure Procedure conducted in inappropriate environment Technical error Post procedureInadequate monitoring (fluid balance, infection) Poor assessment Ward careInadequate monitoring of overall condition, fluid balance, laboratory tests, side effects of medications (especially warfarin), pressure areas and infection Unsafe mobilisation leading to serious falls Hospital acquired infection Prescription of contraindicated drug Delay in undertaking required procedure

4 9 1 Standardised Hospital Mortality Indicator (SHMI ) Hospital Standardised Mortality Ratio (HSMR ) Keogh Review of 14 ‘mortality outliers’

PRISM 2 Study Based on recommendations emerging from the Keogh review Relationship between ‘excess mortality rates’ and actual ‘avoidable deaths’ Study to support introduction of a new national outcome framework indicator “hospital deaths attributable to problems in care” and national standard approach to local mortality review

5c Hospital deaths attributable to problems in care

PRISM 2 Study 2014/2015 Extend PRISM 1 to further 24 Trusts Similar method to permit analyses of combined data from both studies (n=3,400 records) Random sample of Trusts selected across 4 strata of HSMR Trained reviewers (70% current consultants, 30% retired) Linear regression to determine the percentage increase in avoidable death proportion for a 10 point increase in HSMR/SHMI

Findings 78% good or excellent care 9.4% ‘problem in care’ contributing to death 3.0% deaths probably avoidable – range 0% - 9% (low variation between Trusts persists) Inter-rater reliability Kappa 0.35

Combined Findings 3.6% probably avoidable no statistical significant association between hospital SMRs and the proportion of avoidable deaths

The future Local Mortality Review – Standardised self-assessment will ensure robust process National approach to training and materials Electronic database/ NRLS Random sample or all deaths screened, high risk cases selected for in-depth Multidisciplinary process National Tracking of Outcome Indicator Random sample of NHS deaths National panel of trained reviewers (multi-disciplinary) Multiple reviewers per record Timetable: Invitation to tender via HQIP –

The future X Direct comparison of Trusts based on avoidable deaths ?? Develop notional avoidable death proportions Use a coherent set of indicators known to be associated with quality e.g. hospital acquired infections and measure as robustly as possible Develop indicators that reflect integrated care/ quality of care across health systems

Thank you